Yeo lab:Projects
From OpenWetWare
| Line 9: | Line 9: | ||
*[[Yeo_lab:targeting | Developing nanoparticles for tumor targeting]]. | *[[Yeo_lab:targeting | Developing nanoparticles for tumor targeting]]. | ||
*[[Yeo_lab:pulmonary | Pulmonary drug delivery for local therapy]]. | *[[Yeo_lab:pulmonary | Pulmonary drug delivery for local therapy]]. | ||
| - | *[[Yeo_lab:solvent_exchange | Developing growth | + | *[[Yeo_lab:solvent_exchange | Developing growth factor delivery systems for tissue engineering applications]]. |
|}<br style="clear:both" /> | |}<br style="clear:both" /> | ||
Revision as of 00:27, 12 February 2007
Home Research Publications Lab Members Positions Contact Links Internal
|
One of the major obstacles in translating potent drug candidates from bench to bedside is their spatiotemporally adequate delivery. For example, small interfering RNA (siRNA) has been recognized as a promising new class of drugs for viral infections, neurodegenerative diseases, and cancer; however, its therapeutic potential has not been realized because of the instability in circulation and inefficient delivery to the target cells. Target-specific delivery of anti-cancer drugs with minimal side effects on normal tissues has long been a goal for cancer therapy, but their clinical application remains challenging. Dr. Yeo’s lab will focus on developing drug/gene delivery systems which can address these challenges in delivery. Specific research projects include: |
